ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Organogenesis Holdings Inc

Organogenesis Holdings Inc (ORGO)

2,42
-0,06
(-2,42%)
Geschlossen 08 Juni 10:00PM
2,42
0,00
(0,00%)
Nach Börsenschluss: 1:59AM

Organogenesis Holdings Inc (ORGO) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2025-01-10Mr. Brian GrowChief Commercial Officer958,001,19kDerivative Exercise and Retained Stock1,24483,69k0,20%
2026-03-09Mr. Arthur S. LeibowitzLead Independent Director5,00k13,41kKauf2,68242,19k2,11%
2026-03-09Dr. Michael Joseph DriscollIndependent Director10,00k26,69kKauf2,67--
2026-03-01Mr. Robert CavorsiChief Business Officer-700,002,25kSale to Issuer3,21275,52k-0,25%
2026-02-18Mr. Antonio S. MontecalvoInsider-3,78k14,51kSale to Issuer3,84107,02k-3,41%
2026-02-18Mr. Brian GrowChief Commercial Officer-11,89k45,65kSale to Issuer3,84368,56k-3,12%
2026-02-18Mr. Gary S. GillheeneyPresident, CEO, Chair of the Board-91,31k350,63kSale to Issuer3,842,24M-3,91%
2026-02-18Mr. Patrick BilboCOO-16,38k62,88kSale to Issuer3,84603,77k-2,64%
2026-02-18Mr. David C. FranciscoCFO-14,69k56,40kSale to Issuer3,84271,33k-5,13%
2026-02-18Mr. Robert CavorsiChief Business Officer-5,49k21,07kSale to Issuer3,84276,22k-1,95%
2026-02-18Ms. Lori H. FreedmanChief Administrative & Legal Officer-14,41k55,34kSale to Issuer3,84522,35k-2,68%
2026-02-15Mr. Patrick BilboCOO-64,41k240,26kSale to Issuer3,73571,04k-10,14%
2026-02-15Mr. David C. FranciscoCFO-52,45k195,63kSale to Issuer3,73241,98k-17,81%
2026-02-15Mr. Robert CavorsiChief Business Officer-17,66k65,86kSale to Issuer3,73171,51k-9,33%
2026-02-15Mr. Gary S. GillheeneyPresident, CEO, Chair of the Board-271,41k1,01MSale to Issuer3,732,15M-11,23%
2026-02-15Ms. Lori H. FreedmanChief Administrative & Legal Officer-54,74k204,19kSale to Issuer3,73523,93k-9,46%
2026-02-15Mr. Brian GrowChief Commercial Officer-43,96k163,97kSale to Issuer3,73331,63k-11,70%
2026-02-15Mr. Antonio S. MontecalvoInsider-18,62k69,45kSale to Issuer3,7377,91k-19,29%
2025-12-16Mr. Glenn H. NussdorfDirector-200,00k1,03MVerkauf5,1411,75M-1,67%
2025-11-24Mr. Glenn H. NussdorfDirector-300,00k1,59MVerkauf5,29 - 5,3411,95M-2,45%
2025-05-14Mr. Glenn H. NussdorfDirector358,50k1,10MKauf2,99 - 3,0912,25M3,02%
2025-06-09Mr. Glenn H. NussdorfDirector-22,78k80,80kVerkauf3,50 - 3,5612,25M-0,19%
2025-08-11Mr. Brian GrowChief Commercial Officer1,89k4,66kDerivative Exercise and Retained Stock2,47202,42k0,94%
2025-08-11Mr. Brian GrowChief Commercial Officer-2,17k4,66kDerivative Exercise and Sale2,47 - 4,62202,42k-
2025-07-16Mr. Robert CavorsiChief Business Officer-360,001,61kSale to Issuer4,47189,17k-0,19%